Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison

Table 3 Economic and financial costs for MDA delivery, obtained from online WHO regression tool [51] using median input values (see Table 4), and mean GDP per capita weighted by population needed to treat across endemic countries (see Additional file 1: Table S2)

Cost	Economic costs		Financial costs		Reference
Cost	School-based delivery	Community-wide delivery	School-based delivery	Community-wide delivery	Reference
Delivery cost (per person targeted)	US$0.75	US$0.50^a	US$0.31	US$0.34	[52]
PZQ tablets	2.5 × US$0.08 per child	2.5 × US$0.08 per child; 3.5 × US$0.08 per adult	Donated	Donated	[53, 54]

Notes: Economic costs include costs associated with Ministry of Health buildings and time, as well as the value associated with volunteers’ time
^aIncludes US$0.08 per person for the opportunity costs related to the community volunteer who distribute the drugs which is not included with the WHO regression tool [52]